<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/225484-acridine-compounds-a-process-of-preparing-the-same by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 04 Apr 2024 23:59:09 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 225484:ACRIDINE COMPOUNDS A PROCESS OF PREPARING THE SAME.</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">ACRIDINE COMPOUNDS A PROCESS OF PREPARING THE SAME.</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The invention relates to novel acridine derivatives of general formula (1) the production thereof and the use of the same as Pharmaceuticals, especially for treating tumours.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>COMPOUNDS A PROCESS OF PREPARING THE SAME<br>
ACRIDINE DERIVATIVES AND THE THEIR USE AS MEDICAMENTS<br>
The invention relates to novel heteroaryl derivatives<br>
of the formula 1, to their preparation and to their use<br>
as medicaments, in particular for treating tumors.<br>
According to one aspect of the invention, novel<br>
acridine derivatives of the formula 1<br>
in which<br>
R, R1, R2, R3 can be attached to any of the acridine<br>
carbon atoms C1 to C9, are identical or<br>
different and independently of one another<br>
denote hydrogen, straight-chain or branched<br>
(C1-C8) -alkyl, (C3-C7)-cycloalkyl, straight-<br>
chain or branched (Ci-Cs) -alkylcarbonyl,<br>
preferably acetyl, straight-chain or branched<br>
(C1-C8)-alkoxy, halogen, aryl-(C1-C8)-alkoxy,<br>
preferably benzyloxy or phenylethyloxy,<br>
nitro, amino, mono- (C1-C4) -alkylamino, di-<br>
(C1-C4)-alkylamino, (C1-C8) -alkoxycarbonyl-<br>
amino, (C1-C6) -alkoxycarbonylamino- (C1-C8) -<br>
alkyl, cyano, straight-chain or branched<br>
cyano-(C1-C8)-alkyl, carboxyl, C1-C8-alkoxy-<br>
carbonyl, (C1-C4)-alkyl which is substituted<br>
by one or more fluorine atoms, preferably the<br>
trifluoromethyl group, carboxy-(C1-C8)-alkyl<br>
or (C1-C8) -alkoxycarbonyl- (C1-C6) -alkyl,<br>
(C2-C6)-alkenyl, preferably allyl, (C2-C6)-<br>
alkynyl, preferably ethynyl or propargyl,<br>
straight-chain or branched cyano-(C1-C6)-<br>
alkyl, preferably cyanomethyl, aryl, where<br>
the aryl radical may be unsubstituted or<br>
mono- or polysubstituted by identical or<br>
different substituents from the group<br>
consisting of halogen, straight-chain or<br>
branched (C1-C8) -alkyl, (C3-C7) -cycloalkyl,<br>
carboxyl, straight-chain or branched (C1-C8)-<br>
alkoxycarbonyl, preferably tert-butoxy-<br>
carbonyl, by trifluoromethyl, hydroxyl,<br>
straight-chain or branched (C1-C8)-alkoxy,<br>
preferably methoxy or ethoxy, benzyloxy,<br>
nitro, amino, mono-(C1-C4)-alkylamino, di- (C1-<br>
C4)-alkylamino, cyano, straight-chain or<br>
branched cyano- (C1-C6) -alkyl.<br>
substituted on the acridine heterocycle may<br>
be attached to C atoms C1-C9 of the acridine<br>
ring skeleton;<br>
Q independently of one another represent oxygen or<br>
in each case two hydrogen atoms (i.e. -CH2-) ;<br>
is nitrogen or C-R5, where R5 represents hydrogen<br>
or (C1-C6)-alkyl;<br>
n,m independently of one another denotes an integer<br>
between 0-3, with the proviso that in the case n =<br>
0, X denotes a CR5R6 group where R5 and R6<br>
independently of one another represent hydrogen or<br>
(C1-C6)-alkyl and that the nitrogen atom adjacent<br>
to the C=Z group is substituted by a hydrogen atom<br>
or a (C-C6)-alkyl group;<br>
R4 [lacuna] a straight-chain or branched (C1-C20)-<br>
alkyl radical which may be saturated or<br>
unsaturated, with one to three double and/or<br>
triple bonds, and which may be unsubstituted or<br>
may optionally be substituted at the same or<br>
different C atoms by one, two or more aryl,<br>
heteroaryl, halogen, cyano, (C1-C6)-alkoxy-<br>
carbonylamino, (C1-C6) -alkoxy, amino, mono-(C1-C4) -<br>
alkylamino or di-(C1-C4)-alkylamino; a (C6-C14)-aryl<br>
radical, (C6-C14)-aryl-(C1-C6)-alkyl radical or a<br>
(C2-C10)-heteroaryl or (C2-C10) -heteroaryl- (C1-C4) -<br>
alkyl radical which contains one or more hetero-<br>
atoms selected from the group consisting of N, 0<br>
and S, where the {C1-C4)-alkyl radical may be<br>
unsubstituted or mono- [lacuna] polysubstituted by<br>
identical or different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo (=0)<br>
and where the (C6-C14)-aryl or {C2-C10) -heteroaryl<br>
radical may be unsubstituted or mono- or polysubstituted<br>
by identical or different substituents<br>
from the group consisting of straight-chain or<br>
branched (C1-C8) -alkyl, (C3-C7)-cycloalkyl, halogen,<br>
cyano, (C1-C6)-alkoxycarbonylamino, (C1-C6)-<br>
alkoxy, carboxyl, (C1-C8)-alkoxycarbonyl, straight-<br>
chain or branched (C1-C6) -alkyl which is<br>
substituted by one or more fluorine atoms,<br>
preferably trifluoromethyl, hydroxyl, straight-<br>
chain or branched (C1-C8)-alkoxy, preferably<br>
methoxy or ethoxy, where adjacent oxygen atoms may<br>
also be linked by (C1-C2)-alkylene groups,<br>
preferably by a methylene group, benzyloxy, nitro,<br>
amino, mono-(C1-C4)-alkylamino, di- (C1-C4)-alkyl-<br>
amino, aryl, which for its part may be<br>
unsubstituted or mono- or polysubstituted by<br>
identical or different substituents from the group<br>
consisting of straight-chain or branched (C1-C8)-<br>
alkyl, (C3-C7)-cycloalkyl, carboxyl, straight-chain<br>
or branched (C1-C8)-alkoxycarbonyl, by trifluoro-<br>
methyl, hydroxyl, straight-chain or branched (C1-<br>
C8),-alkoxy, preferably methoxy or ethoxy,<br>
benzyloxy, nitro, amino, mono-(C1-C4)-alkylamino,<br>
di-(C1-C4)-alkylamino, cyano, straight-chain or<br>
branched cyano- (C1-C6) -alkyl ;<br>
and their structural isomers and stereoisomers, in<br>
particular tautomers, diastereomers and<br>
enantiomers, and their pharmaceutically acceptable<br>
salts, in particular acid addition salts, are<br>
provided.<br>
Thus, for example, the compounds of the formula (1)<br>
according to the invention which have one or more<br>
centers of chirality and which are presenf-as racemates"<br>
can be separated by methods Known per se into their<br>
optical isomers, i.e. enantiomers or diastereomers. The-<br>
separation can be carried out by column separation on<br>
chiral phases or by recrystallization.. from an optically<br>
active solvent or using an optically active acid or<br>
base or by derivatization with__an optically active<br>
reagent, such as.,for example an optically active<br>
alcohol, and subsequent removal of the radical.<br>
Furthermore, the acridine derivatives of the formula<br>
(1) according to the invention can be converted into<br>
their salts with inorganic or organic acids, in<br>
particular, for pharmaceutical use, into their<br>
physiologically acceptable salts. Acids which are<br>
suitable for this purpose are, for example,<br>
hydrochloric acid, hydrobromic acid, sulfuric acid,<br>
phosphoric acid, fumaric acid, succinic acid, lactic<br>
acid, citric acid, acetic acid, tartaric acid, malic<br>
acid, malonic acid, embonic acid, trifluoroacetic acid<br>
or maleic acid.<br>
Moreover, the compounds of the formula (1) according to<br>
the invention can, if they contain a sufficiently-<br>
acidic group, such as a carboxyl group, be converted,<br>
if desired, into their salts with inorganic or organic<br>
bases, in particular, for pharmaceutical use, into<br>
their physiologically acceptable salts. Bases which are<br>
suitable for this purpose are, for example, sodium<br>
hydroxide, potassium hydroxide, calcium hydroxide,<br>
lysine, cyclohexylamine, ethanolamine, diethanolamine<br>
and triethanolamine.<br>
According to a preferred embodiment, acridine<br>
derivatives of the formula 1 are provided in which R,<br>
Rl, R2, R3, X, Z, P, Q, n and m have the meanings given<br>
above and<br>
R4 denotes a straight-chain or branched (C1-C20)-alkyl<br>
radical which may be saturated or unsaturated,<br>
with one to three double and/or triple bonds, and<br>
which may be unsubstituted or optionally<br>
substituted on the same or different C atoms by<br>
one, two or more aryl, heteroaryl, halogen,<br>
(C1-C6)-alkoxy, amino, mono-(C1-C4)-alkylamino or<br>
di- (C1-C4) -alkylamino;<br>
a phenyl ring or a naphthyl ring, each of which<br>
may be unsubstituted or mono- or polysubstituted<br>
by identical or different substituents from the<br>
group consisting of straight-chain or branched<br>
(C1-C8) -alkyl, (C3-C7)-cycloalkyl, halogen, cyano,<br>
(C1-C6)-alkoxycarbonylamino, (C1-C6)-alkoxy, carboxyl,<br>
(C1-C8)-alkoxycarbonyl, straight-chain or<br>
branched (C1-C6)-alkyl which is substituted by one<br>
or more fluorine atoms, preferably trifluoro-<br>
methyl, hydroxyl, straight-chain or branched<br>
(C1-C8)-alkoxy, preferably methoxy or ethoxy, where<br>
adjacent oxygen atoms may also be linked by<br>
(C1-C2)-alkylene groups, preferably a methylene<br>
group, benzyloxy, nitro, amino, mono-(C1-C4)-alkyl-<br>
amino, di-(C1-C4)-alkylamino, aryl, which for its<br>
part may be unsubstituted or mono- or poly-<br>
substituted by identical or different substituents<br>
from the group consisting of straight-chain or<br>
branched (C1-C8) -alkyl, (C3-C7)-cycloalkyl, car-<br>
boxyl, straight-chain or branched (C1-C8)-alkoxy-<br>
carbonyl, by trifluoromethyl, hydroxyl, straight-<br>
chain or branched (C1-C8)-alkoxy, preferably<br>
methoxy or ethoxy, benzyloxy, nitro, amino, mono-<br>
(C1-C4)-alkylamino, di-(C1-C4)-alkylamino, cyano,<br>
straight-chain or branched cyano-(C1-C6)-alkyl;<br>
a 2-, 4-, 5- or 6-pyrimidinyl radical or 2-, 4-,<br>
5- or 6-pyrimidinyl-(C1-C4)-alkyl radical, where<br>
the (C1-C4)-alkyl radical may be unsubstituted or<br>
mono- [lacuna] polysubstituted by identidal or<br>
different substituents from the group consisting<br>
of (C1-C6)-alkyl, halogen and oxo (=0) and the 2-,<br>
4-, 5- or 6-pyrimidinyl radical may be unsubstituted<br>
or mono- to trisubstituted by identical<br>
or different substituents from the group consisting<br>
of hydrogen, (C1-C6)-alkyl, halogen, nitro,<br>
amino, mono- (C1-C6)-alkylamino, di-(C1-C6)-alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, car-<br>
boxyl, (C1-C6)-alkoxycarbonyl, (C1-C6) -alkoxycar-<br>
bonylamino or (C1-C6)-alkyl which is mono- or polysubstituted<br>
by fluorine, preferably trifluoro-<br>
methyl, (C1-C10)-aryl and (C1-C10)-aryl-(C1-C6)-<br>
alkyl;<br>
a 3-, 4-, 5- or 6-pyridazinyl radical or 3-, 4-,<br>
5- or 6-pyridazinyl-(C1-C4)-alkyl radical, where<br>
the (C1-C4)-alkyl radical may be unsubstituted or<br>
mono- [lacuna] polysubstituted by identical or<br>
different substituents from the group consisting<br>
of (C1-C6)-alkyl, halogen and oxo (=0) and the 3-,<br>
4-, 5- or 6-pyridazinyl radical may be unsub-<br>
stituted or mono- to trisubstituted by identical<br>
or different substituents from the group<br>
consisting of hydrogen, (C1-C6)-alkyl, halogen,<br>
nitro, amino, mono- (C1-C6) -alkylamino, di-(C1-C6)-<br>
alkylamino, hydroxyl, (C1-C6)-alkoxy, benzyloxy,<br>
carboxyl, (C1-C6)-alkoxycarbonyl, (C1-C6) -alkoxy-<br>
carbonylamino or (C1-C6)-alkyl which is mono- or<br>
polysubstituted by fluorine, preferably trifluoro-<br>
methyl, (C6-C10)-aryl and (C6-C10)-aryl-(C1-C6)-<br>
alkyl;<br>
a 2-, 3-,- 5- or 6-pyrazinyl radical or 2-, 3-,5-<br>
or 6-pyrazinyl-(C1-C4)-alkyl radical, where the<br>
(C1-C4)-alkyl radical may be unsubstituted or mono-<br>
[lacuna] polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 2-, 3-, 5- or<br>
6-pyrazinyl radical may be unsubstituted or mono-<br>
to trisubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6) -alkyl which is mono- or polysubstituted<br>
by fluorine, preferably trifluoromethyl, (C6-C10)-<br>
aryl and (C6-C10) -aryl- (C1-C6) -alkyl ;<br>
a 3-, 4-, 5-, 6-, 7-, or 8-C1nnolinyl radical or<br>
3-, 4-, 5-, 6-, 7-, or 8-C1nnolinyl- (C1-C4) -alkyl<br>
radical, where the (C1-C4)-alkyl radical may be<br>
unsubstituted or mono- [lacuna] polysubstituted by<br>
identidal or different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo (=0)<br>
and the 3-, 4-, 5-, 6-, 7-, or 8-C1nnolinyl<br>
radical may be unsubstituted or mono- to<br>
pentasubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl, (C1-<br>
C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino or<br>
(C1-C6) -alkyl which is mono- or polysubstituted by<br>
fluorine, preferably trif luoromethyl, (C6-C10) -aryl<br>
and (C6-C10)-aryl-(C1-C6)-alkyl;<br>
a 2-, 4-, 5-, 6-, 7-, or 8-quinazolinyl radical or<br>
2-, 4-, 5-, 6-, 7-, or 8-quinazolinyl-(C1-C4)-alkyl<br>
radical, where the (C1-C4) -alkyl radical may be<br>
unsubstituted or mono- [lacuna] polysubstituted by<br>
identidal or different substituents from the group<br>
consisting of hydrogen, (C1-C6) -alkyl, halogen and<br>
oxo (=0) and the or [sic] 2-, 4-, 5-, 6-, 7-, or<br>
8-quinazolinyl radical may be unsubstituted or<br>
mono- to pentasubstituted by identical or<br>
different substituents from the group consisting<br>
of hydrogen, (C1-C6) -alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl, (C1-<br>
C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino or<br>
(C1-C6)-alkyl which is mono- or polysubstituted by<br>
fluorine, preferably trif luoromethyl, (C6-C10) -aryl<br>
and (C6-C10)-aryl-(C1-C6)-alkyl ;<br>
a 2-, 3-, 5-, 6-, 7-, or 8-quinoxalinyl radical<br>
[lacuna] 2-, 3-, 5-, 6-, 7-, or 8-quinoxalinyl-<br>
(C1-C4)-alkyl radical, where the (C1-C4)-alkyl<br>
radical may be unsubstituted or mono- [lacuna]<br>
polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the or [sic] 2-,<br>
3-, 5-, 6-, 7-, or 8-quinoxalinyl radical may be<br>
unsubstituted or mono- to pentasubstituted by<br>
identical or different substituents from the group<br>
consisting of hydrogen, (C1-C6) -alkyl, halogen,<br>
nitro, amino, mono- (C1-C6) -alkylamino, di-(C1-C6)-<br>
alkylamino, hydroxyl, (C1-C6)-alkoxy, benzyloxy,<br>
carboxyl, (C1-C6)-alkoxycarbonyl, (C1-C6) -alkoxy-<br>
carbonylamino or (C1-C6)-alkyl which is mono- or<br>
polysubstituted by fluorine, preferably trifluoro-<br>
methyl, (C6-C10)-aryl and (C6-C10) -aryl- (C1-C6) -<br>
alkyl;<br>
a 1-, 4-, 5-, 6-, 7-, or 8-phthalazinyl radical or<br>
1-, 4-, 5-, 6-, 7-, or 8-phthalazinyl-(C1-C4)-alkyl<br>
radical, where the (C1-C4)-alkyl radical may be<br>
unsubstituted or mono- [lacuna] polysubstituted by<br>
identidal or different substituents from the group<br>
consisting of (C1-C6)-alkyl, halogen and oxo (=0)<br>
and the or [sic] 1-, 4-, 5-, 6-, 7-, or 8-<br>
phthalazinyl radical may be unsubstituted or mono-<br>
to pentasubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl, (C1-<br>
C6)-alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino or<br>
(C1-C6)-alkyl which is mono- or polysubstituted by<br>
fluorine, preferably trifluoromethyl, (C6-C10)-aryl<br>
and (C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 2-, 3-, 4-, 5-, 6-, 7- or 8-quinolyl radical or<br>
2-, 3-, 4-, 5-, 6-, 7 or 8-quinolyl- (C1-C4) -alkyl<br>
radical, where the (C1-C4) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the group<br>
consisting of (C1-C6)-alkyl, halogen and oxo (=0)<br>
and the 2-, 3-, 4-, 5-, 6-, 7- or 8-quinolyl<br>
radical may be unsubstituted or mono- to hexa-<br>
substituted by identical or different substituents<br>
from the group consisting of hydrogen, (C1-C6)-<br>
alkyl, preferably methyl, particularly preferably<br>
2-methyl, halogen, nitro, amino, mono- (C1-C6) -<br>
alkylamino, di- (C1-C6) -alkylamino, hydroxyl, (C1-<br>
C6)-alkoxy, benzyloxy, carboxyl, (C1-C6)-alkoxy-<br>
carbonyl, (C1-C6) -alkoxycarbanylami.no or (C1-C6)-<br>
alkyl which is mono- or polysubstituted by<br>
fluorine, preferably trifluoromethyl, (C6-C10)-aryl<br>
and (C6-C10)-aryl-(C1-C6)-alkyl;<br>
a 1-, 3-, 4-, 5-, 6-, 7- or 8-isoquinolyl radical<br>
or 1-, 3-, 4-, 5-, 6-, 7- or 8-isoquinolyl-(C1-C4) -<br>
alkyl radical, where the (C1-C4)-alkyl radical may<br>
be unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the group<br>
consisting of (C1-C6)-alkyl, halogen and oxo (=0)<br>
and the 1-, 3-, 4-, 5-, 6-, 7- or 8-isoquinolyl<br>
radical may be unsubstituted or mono- to<br>
hexasubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl, (C1-<br>
C6)-alkoxycarbonyl, (C1-C6)-alkoxycarbonylamino or<br>
(C1-C6) -alkyl which is mono- or polysubstituted by<br>
fluorine, preferably trifluoromethyl, (C6-C10)-aryl<br>
and (C6-C10)-aryl-(C1-C6)-alkyl;<br>
a 2-, 6-, 8- or 9- [9H] -purinyl radical or 2-, 6-,<br>
8- or 9-[9H]-purinyl-(C1-C4)-alkyl radical, where<br>
the (C1-C4)-alkyl radical may be unsubstituted or<br>
mono- or polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 2-, 6-, 8- or<br>
9-[9H]-purinyl radical may be unsubstituted or<br>
mono- to trisubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl, (C1-<br>
C6)-alkoxycarbonyl, (C1-C6)-alkoxycarbonylamino or<br>
(C1-C6) -alkyl which is mono- or polysubstituted by<br>
fluorine, preferably trifluoromethyl, (C6-C10)-aryl<br>
and (C6-C10)-aryl-(C1-C6)-alkyl;<br>
a 2-, 6-, 7- or 8- [1H] -purinyl radical or 2-, 6-,<br>
7- or 8-[7H]-purinyl-(C1-C4)-alky 1 radical, where<br>
the (C1-C4) -alkyl radical may be unsubstituted or<br>
mono- or polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 2-, 6-, 7- or<br>
8-[7H]-purinyl radical may be unsubstituted or<br>
mono- to trisubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6) -alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6) -alkoxy, benzyloxy, carboxyl, (C1-<br>
C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino or<br>
(C1-C6) -alkyl which is mono- or polysubstituted by<br>
fluorine, preferably trif luoromethyl, (C6-C10) -aryl<br>
and (C6-C10)-aryl-(C1-C6)-alkyl;<br>
a 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-acridinyl<br>
radical or 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-<br>
acridinyl-(C1-C4) -alkyl radical, where the (C1-C6)-<br>
alkyl radical may be unsubstituted or mono- or<br>
polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 1-, 2-, 3-, 4-<br>
, 5-, 6-, 7-, 8- or 9-acridinyl radical may be<br>
unsubstituted or mono- to octasubstituted by<br>
identical or different substituents from the group<br>
consisting of hydrogen, (C1-C6)-alkyl, halogen,<br>
nitro, amino, mono- (C1-C6) -alkylamino, di-(C1-C6)-<br>
alkylamino, hydroxyl, (C1-C6)-alkoxy, benzyloxy,<br>
carboxyl, (C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6)-alkyl which is mono- or<br>
polysubstituted by fluorine, preferably trifluoromethyl,<br>
(C6-C10)-aryl and (C6-C10) -aryl- (C1-C6) -<br>
alkyl;<br>
a 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-<br>
phenanthridinyl radical or 1-, 2-, 3-, 4-, 5-, 6-,<br>
7-, 8- or 9-phenanthridinyl-(C1-C6)-alkyl radical,<br>
where the (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the group<br>
consisting of hydrogen, (C1-C6) -alkyl, halogen and<br>
oxo (=0) and the 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or<br>
9-phenanthridinyl radical may be unsubstituted or<br>
mono- to octasubstituted by identical or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen, nitro, amino, mono- (C1-C6) -alkyl-<br>
amino, di- (C1-C6) -alkylamino, hydroxyl, (C1-C6)-<br>
alkoxy, (C6-C10) -aryl- (C1-C6) -alkoxy, preferably<br>
benzyloxy, carboxyl, (C1-C6) -alkoxycarbonyl,<br>
(C1-C6) -alkoxycarbonylamino or (C1-C6) -alkyl which<br>
is mono- or polysubstituted by fluorine,<br>
preferably trifluoromethyl, (C6-C10) -aryl and (C6-<br>
C10)-aryl- (C1-C6) -alkyl;<br>
a 2-, 3-, 4-, 5- or 6-pyridyl radical where the<br>
2-, 3-, 4-, 5- or 6-pyridyl radical may be<br>
unsubstituted or mono- to tetrasubstituted by<br>
identical or different substituents from the group<br>
consisting of hydrogen, (C1-C6) -alkyl, halogen,<br>
nitro, amino, mono- (C1-C6) -alkylamino, di-(C1-C6)-<br>
alkylamino, hydroxyl, (C1-C6)-alkoxy, benzyloxy,<br>
carboxyl, (C1-C6)-alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6)-alkyl which is mono- or<br>
polysubstituted by fluorine, preferably trifluoromethyl,<br>
(C6-C10)-aryl and (C6-C10) -aryl- (C1-C6) -<br>
alkyl;<br>
a 2-, 3-, 4-, 5- or 6-pyridinyl-(C1-C6)-alkyl<br>
radical, where the (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identical or different substituents from the group<br>
consisting of (C1-C6)-alkyl, halogen and oxo (=0)<br>
and the 2-, 3-, 4-, 5- or 6-pyridinyl radical may<br>
be unsubstituted or mono- to tetrasubstituted by<br>
identical or different substituents from the group<br>
consisting of hydrogen, (C1-C6) -alkyl, halogen,<br>
nitro, amino, mono-(C1-C6)-alkylamino, di-(C1-C6)-<br>
alkylamino, hydroxyl, (C1-C6)-alkoxy, benzyloxy,<br>
carboxyl, (C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxy-<br>
carbonylamino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluorine, preferably trifluoro-<br>
methyl, (C6-C10) -aryl and (C6-C10) -aryl- (C1-C6) -<br>
alkyl;<br>
a 2-, 3-, 4- or 5-thienyl radical or 2-, 3-, 4- or<br>
5-thienyl-(C1-C6) -alkyl radical, where the (C1-C6) -<br>
alkyl radical may be unsubstituted or mono- or<br>
polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 2-, 3-, 4- or<br>
5-thienyl radical may be unsubstituted or mono- to<br>
trisubstituted by identical or different substituents<br>
from the group consisting of hydrogen,<br>
(C1-C6) -alkyl, halogen, nitro, amino, mono- (C1-C6) -<br>
alkylamino, di-(C1-C6)-alkylamino, hydroxyl, (C1-<br>
C6)-alkoxy, benzyloxy, carboxyl, (C1-C6)-alkoxycarbonyl,<br>
C1-C6) -alkoxycarbonylamino or (C1-C6)-<br>
alkyl which is mono- or polysubstituted by<br>
fluorine, preferably trifluoromethyl, (C6-C10)-aryl<br>
and (C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 2-, 4-, or 5-thiazolyl radical or 2-, 4-, or 5-<br>
thiazolyl-(C1-C6)-alkyl radical, where the (C1-C6)-<br>
alkyl radical may be unsubstituted or mono- or<br>
polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6) -<br>
alkyl, halogen and oxo (=0) and the 2-, 4-, or 5-<br>
thiazolyl radical may be unsubstituted or mono- or<br>
disubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- {C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6)-alkyl which is mono- or polysubstituted<br>
by fluorine,,preferably trifluoromethyl, (C6-C10)-<br>
aryl and (C6-C10)-aryl-(C1-C6)-alkyl;<br>
a 3-, 4-, or 5-isothiazolyl radical or 3-, 4-, or<br>
5-isothiazolyl-(C1-C6) -alkyl radical, where the<br>
(C1-C6)-alkyl radical may be unsubstituted or mono-<br>
or polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 3-, 4-, or 5-<br>
isothiazolyl radical may be unsubstituted or mono-<br>
or disubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6) -alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6) -alkyl which is mono- or polysubstituted<br>
by fluorine, preferably trif luoromethyl, (C6-C10)-<br>
aryl and (C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 2-, 4-, 5-, 6-, or 7-benzothiazolyl radical or<br>
2-, 4-, 5-, 6-, or 7-benzothiazolyl- (C1-C6) -alkyl<br>
radical, where the (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo (=0)<br>
and the 2-, 4-, 5-, 6-, or 7-benzothiazolyl<br>
radical may be unsubstituted or mono- to<br>
tetrasubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6) -alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6) -alkyl which is mono- or polysubstituted<br>
by fluorine, preferably trif luoromethyl, (C6-C10)-<br>
aryl and (C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 1-, 2-, 4-, or 5-imidazolyl radical or 1-, 2-,<br>
4-, or 5-imidazolyl-(C1-C6)-alkyl radical, where<br>
the (C1-C6) -alkyl radical may be unsubstituted or<br>
mono- or polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 1-, 2-, 4-, or<br>
5-imidazolyl radical may be unsubstituted or mono-<br>
to trisubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C3-C6) -alkoxycarbonylamino<br>
or (C1-C6) -alkyl which is mono- or polysubstituted<br>
by fluorine, preferably trifluoromethyl, (C6-C10)-<br>
aryl and (C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 1-, 3-, 4-, or 5-pyrazolyl radical or 1-, 3-, 4-<br>
or 5-pyrazolyl-(C1-C6)-alkyl radical, where the<br>
(C1-C6)-alkyl radical may be unsubstituted or mono-<br>
or polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 1-, 3-, 4- or<br>
5-pyrazolyl radical may be unsubstituted or mono-<br>
to trisubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6) -alkyl which is mono- or polysubstituted<br>
by fluorine, preferably trifluoromethyl, (C6-C10)-<br>
aryl and (C6-C10) -aryl- (C1-C6) -alkyl ;<br>
a 1-, 2-, 3-, 4-, or 5-pyrrolyl radical or 1-, 2-,<br>
3-, 4-, or 5-pyrrolyl-(C1-C6)-alkyl radical, where<br>
the (C1-C6) -alkyl radical may be unsubstituted or<br>
mono- or polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 1-, 2-, 3-, 4-<br>
or 5-pyrrolyl radical may be unsubstituted or<br>
mono- to tetrasubstituted by identical or<br>
different substituents from the group consisting<br>
of hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6)-alkyl which is mono- or polysubstituted<br>
by fluorine, preferably trifluoromethyl, (C6-C10)-<br>
aryl and (C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 1-, 3-, or 5-[1.2.4]-triazolyl radical or 1-,<br>
3-, or 5-[1.2.4]-triazolyl-(C1-C6)-alkyl radical,<br>
where the (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the group<br>
consisting of hydrogen, (C1-C6) -alkyl, halogen and<br>
oxo (=0) and the 1-, 3-, or 5-[1.2.4]-triazolyl<br>
radical may be unsubstituted or mono- or<br>
disubstituted by identical or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen, nitro, amino, mono-(C1-C6)-alkylamino,<br>
di- (C1-C6) -alkylamino, hydroxyl, (C1-C6)-<br>
lkoxy, benzyloxy, carboxyl, (d-C6)-alkoxycarbonyl,<br>
(C1-C6) -alkoxycarbonylamino or (C1-C6)-<br>
alkyl which is mono- or polysubstituted by<br>
fluorine, preferably trifluoromethyl, (C6-C10)-aryl<br>
and (C6-C1o) -aryl- (C1-C6) -alkyl;<br>
a 1-, 4-, or 5- [1.2.3]-triazolyl radical or 1-,<br>
4-, or 5-[1.2.3]-triazolyl-(C1-C6)-alkyl radical,<br>
where the (C1-C6)-alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo (=0)<br>
and the 1-, 4-, or 5-[1.2.3]-triazolyl radical may<br>
be unsubstituted or mono- or disubstituted by<br>
identical or different substituents from the group<br>
consisting of hydrogen, (C1-C6) -alkyl, halogen,<br>
nitro, amino, mono- (C1-C6) -alkylamino, di-(C1-C6)-<br>
alkylamino, hydroxyl, (C1-C6) -alkoxy, benzyloxy,<br>
carboxyl, . (C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxy-<br>
carbonylamino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluorine, preferably trifluoro-<br>
methyl, (C6-C10) -aryl and (C6-C10) -aryl- (C1-C6) -<br>
alkyl;<br>
a 1- or 5-[lff]-tetrazolyl radical or 1-, or 5-<br>
[1H]-tetrazolyl-(C1-C6)-alkyl radical, where the<br>
(C1-C6)-alkyl radical may be unsubstituted or mono-<br>
or polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 1-, or 5-[lH]-<br>
tetrazolyl radical may be unsubstituted or<br>
substituted by hydrogen, (C1-C6)-alkyl, halogen,<br>
nitro, amino, mono-(C1-C6)-alkylamino, di-(C1-C6)-<br>
alkylamino, hydroxyl, (C1-C6) -alkoxy, benzyloxy,<br>
carboxyl, (C1-C6) -alkoxycarbonyl, (C1-C6)-alkoxy-<br>
carbonylamino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluorine, preferably trifluoro-<br>
methyl, (C6-C10) -aryl and (C6-C10)-aryl-(C1-C6)-<br>
alkyl;<br>
a 2- or 5-[2H]-tetrazoyl radical or 2- or 5-[2H]-<br>
tetrazolyl-(C1-C6)-alkyl radical, where the (C1-<br>
C6)-alkyl radical may be unsubstituted or mono- or<br>
polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 2- or 5-[2H]-<br>
tetrazplyl radical may be unsubstituted or<br>
substituted by hydrogen, (C1-C6)-alkyl, halogen,<br>
nitro, amino, mono-(C1-C6)-alkylamino, di-(C1-C6)-<br>
alkylamino, hydroxyl, (C1-C6)-alkoxy, benzyloxy,<br>
carboxyl, (C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxy-<br>
carbonylamino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluorine, preferably trifluoro-<br>
methyl, (C6-C10) -aryl and (C6-C10) -aryl- (C1-C6) -<br>
alkyl;<br>
a 2-, 4-, or 6- [1.3.5] -triazinyl radical or 2-,<br>
4-, or 6-[1.3. 5]-triazinyl-(C1-C6)-alkyl radical,<br>
where the . (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the group<br>
consisting of hydrogen, (C1-C6) -alkyl, halogen and<br>
oxo (=0) and the 2-, 4-, or 6-[1.3.5]-triazinyl<br>
radical may be unsubstituted or mono- or<br>
disubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6) -alkyl which is mono- or polysubstituted<br>
by fluorine, preferably trifluoromethyl, (C6-C10)-<br>
aryl and (C6-C10) -aryl- (C1-C6) -alkyl ;<br>
a 2-, 4-, or 5-oxazolyl radical or 2-, 4-, or<br>
5-oxazolyl-(C1-C6)-alkyl radical, where the<br>
(C1-C6) -alkyl radical may be unsubstituted or mono-<br>
or polysubstituted by identidal or different<br>
substituents from the group consisting of (C3.-C6)-<br>
alkyl, halogen and oxo (=0) and the 2-, 4-, or<br>
5-oxazolyl radical may be unsubstituted or mono-<br>
or disubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6)-alkyl which is mono- or polysubstituted<br>
by fluorine, preferably trifluoromethyl, (C6-C10)-<br>
aryl and (C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 3-, 4-, or 5-isoxazolyl radical or 3-, 4-, or<br>
5-isoxazolyl-(C1-C6)-alkyl radical, where the<br>
(C1-C6) -alkyl radical may be unsubstituted or mono-<br>
or polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-<br>
alkyl, halogen and oxo (=0) and the 3-, 4-, or<br>
5-isoxazolyl radical may be unsubstituted or mono-<br>
or disubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6) -alkyl which is mono- or polysubstituted<br>
by fluorine, preferably trifluoromethyl, (C6-C10)-<br>
aryl and {C6-C10) -aryl- (C1-C6) -alkyl ;<br>
a 1-, 2-, 3-, 4-, 5-, 6- or 7-indolyl radical or<br>
1-, 2-, 3-, 4-, 5-, 6- or 7-indolyl-(C1-C6)-alkyl<br>
radical, where the (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo (=0)<br>
and the 1-, 2-, 3-, 4-, 5-, 6- or 7-indolyl<br>
radical may be unsubstituted or mono- to<br>
hexasubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino<br>
or (C1-C6) -alkyl which is mono- or polysubstituted<br>
by fluorine, preferably trifluoromethyl, (C6-C10)-<br>
aryl and (C6-C10) -aryl- (C1-C6) -alkyl and the<br>
isomers, in particular tautomers, diastereomers<br>
and enantiomers, and the pharmaC6utically<br>
acC6ptable salts, in particular aC1d addition<br>
salts, thereof.<br>
According to a further embodiment, acR1dine deR1vatives<br>
of the formula (1) are provided which are characteR1zed<br>
in that R, R1, R2, R3, X, Z, P, Q, n and m have the<br>
meanings given above and R4 represents phenyl which is<br>
unsubstituted or substituted by one to five identical<br>
or different (C1-C6)-alkoxy groups, where adjaC6nt<br>
oxygen atoms may also be linked by (C1-C2) -alkylene<br>
groups.<br>
According to a further embodiment, acridine derivatives<br>
of the formula (1) are provided which are characterized<br>
in that R, R1, R2, R3, X, Z, P, Q, n and m have the<br>
meanings given above and R4 represents 3,5-<br>
dimethoxyphenyl.<br>
According to a further embodiment, acridine derivatives<br>
of the formula (1) are provided which are characterized<br>
in that and [sic] R4 has the meanings given above, R,<br>
R1/ R2/ R3 each represent a hydrogen atom, Z represents<br>
an oxygen atom and X represents a nitrogen atom, P and<br>
Q each represent two hydrogen atoms (i.e. -CH2-), m is<br>
zero and n is the integer 2.<br>
According to a further embodiment, acridine derivatives<br>
of the formula (1) are provided which are characterized<br>
in that R, R1, R2 and R3 each represent a hydrogen atom,<br>
Z represents an oxygen atom and X represents a nitrogen<br>
atom, P and Q each represent two hydrogen atoms (i.e. -<br>
CH2-), m is zero, n represents the integer 2 and R4<br>
represents a 3,5-dimethoxyphenyl radical.<br>
According to a further aspect of the invention, a<br>
proC6ss for preparing acridine derivatives according to<br>
any of claims 1 to 6 [lacuna], characterized in that an<br>
acridine carboxylic aC1d of the formula (2) in which R,<br>
R1, R2, R3 have the meanings given above, Z denotes an<br>
oxygen or sulfur atom and Y represents a leaving group<br>
such as halogen, hydroxyl, (C1-C6)-alkoxy, preferably<br>
methoxy or ethoxy, -O-tosyl, -O-mesyl or imidazolyl,<br>
Formula 3<br>
is reacted with an amine of the formula (3) in which<br>
R4, P, Q, X, m and n are as defined above, using, if<br>
appropR1ate, diluents and auxiliaR1es, and the desired<br>
acR1dine deR1vatives are formed.<br>
Synthesis route:<br>
The compounds of the formula 1 can be obtained<br>
according to Scheme 1 below:<br>
The starting mateR1als (2) and (3) are either<br>
commerC1ally available or can be prepared by proC6dures<br>
known per se. The starting mateR1als (2) and (3) are<br>
useful intermediates for prepaR1ng the acR1dine<br>
deR1vatives of the formula (1) according to the<br>
invention.<br>
The solvents and auxiliaR1es to be used, if<br>
appropR1ate, and the reaction parameters to be used,<br>
such as reaction temperature and reaction time, are<br>
known to the person skilled in the art owing to his<br>
expert knowledge.<br>
The acR1dine deR1vatives of the formula (1) according<br>
to the invention are suitable as medicaments, in<br>
particular as antitumor agents, for treating mammals,<br>
in particular man, but also domestic animals such as<br>
horses, cattle, dogs, cats, hares, sheep, poultry and<br>
the like.<br>
According to a further aspect of the invention, a<br>
method for controlling tumors in mammals, in particular<br>
man, is provided which is characteR1zed in that at<br>
least one acR1dine deR1vative of the formula (1) is<br>
administered to a mammal in an amount effective for the<br>
treatment of the tumor. The therapeutically effective<br>
dose of the acR1dine deR1vative according to the<br>
invention in question which is to be administered for<br>
the treatment depends inter alia on the nature and the<br>
stage of the oncosis, the age and the sex of the<br>
patient, the type of administration and the duration of<br>
the treatment. Administration can take plaC6 orally,<br>
rectally, buccally (for example sublingually),<br>
parenterally (for example subcutaneously, intra-<br>
muscularly, intradermally or intravenously), topically<br>
or transdermally.<br>
According to a further aspect of the invention,<br>
medicaments for the treatment of tumors are provided<br>
which are characteR1zed in that they compR1se, as<br>
active ingredient, at least one acR1dine deR1vative<br>
according to any of Claims 1 to 4 or a pharmaC6utically<br>
acC6ptable salt thereof, if appropR1ate together with<br>
customary pharmaC6utically acC6ptable auxiliaR1es,<br>
additives and carR1ers. These can be solid, semisolid,<br>
liquid or aerosol preparations. Suitable solid<br>
preparations are, for example, capsules, powders,<br>
granules, tablets. Suitable semisolid preparations are,<br>
for example, ointments, creams, gels, pastes,<br>
suspensions, oil-in-water and water-in-oil emulsions.<br>
Suitable liquid preparations are, for example, steR1le<br>
aqueous preparations for parenteral administration<br>
which are isotonic with the blood of the patient.<br>
The invention is to be illustrated in more detail by<br>
the example below, without being restR1cted to the<br>
example.<br>
Working Example<br>
1-(3,5-Dimetboxyphenyl)-4-(9-acR1dinyl-<br>
(D-43411) carbonyl)piperazine<br>
8 g (35.84 mmol) of acR1dine-9-carboxylic aC1d were<br>
charged to 300 ml of DMF with stirR1ng. 5.79 g<br>
(57.34 mmol) of N-methylmorpholine, then a solution of<br>
24.24 g (46.59 mmol) of Py-BOP (1-benzotR1azolyltR1-<br>
pyrrolidinophosphonium hexafluorophosphate) and 7.96 g<br>
[lacuna] (35.81 mmol) of 1-(3, 5-dimethoxyphenyl)-<br>
piperazine in 50 ml of DMF were added sucC6ssively to<br>
the mixture with further stirR1ng. The mixture was<br>
stirred, at room temperature for 12 hours, the DMF was<br>
distilled off under reduC6d pressure and the residue<br>
was puR1fied on a silica gel column (Kieselgel 60, from<br>
Merck AG, Darmstadt) using the mobile phase<br>
dichloromethane/methanol/ (95:5 v/v).<br>
Yield: 12.9 (84.2% of theory)<br>
m.p.: 172-175°C<br>
1. Antiproliferative action in vaR1ous tumor C6ll<br>
lines<br>
In a proliferation test, the antiproliferative activity<br>
of the substanC6 D-43411 was examined using established<br>
tumor C6ll lines. In the test used, the C6llular<br>
dehydrogenation activity is determined, which makes it<br>
possible to determine the vitality of the C6ll and,<br>
indirectly, the C6ll count. The C6ll lines used are the<br>
human C6rvical carC1noma C6ll lines KB/HeLa<br>
(ATCC/CCL17) , the muR1ne lymphocyte leukaemia L1210<br>
(ATCC CCL-219), the human breast adenocarC1noma line<br>
MCF7 /ATCC HTB22) and the ovary adenocarC1noma line<br>
SKOV-3 (ATCC HTB77). These are established C6ll lines<br>
which are very well characteR1zed and were obtained<br>
from ATCC and cultured.<br>
The results shown in Tab. 1 demonstrate the highly<br>
potent antiproliferative action of D-43411 in the C6ll<br>
lines SKOV-3, L-1210 and HeLa/KB. Owing to the<br>
particularly slow growth of the MCF7 line, the effect<br>
of D-43411 in the test peR1od of 48 h is only small<br>
(18% inhibition at 3.16 mg/ml; thus stated as &gt;3.16).<br>
2. Method<br>
XTT Test for C6llular dehydrogenase activity<br>
The adherently growing tumor C6ll lines HeLa/KB, SKOV-3<br>
and MCF7 and the L1210 leukaemia line, which grows in<br>
suspension, were cultivated under standard conditions<br>
in an incubator with gas inlet at 37°C, 5% C02 and 95%<br>
atmospheR1c humidity. On Test Day 1, the adherent C6lls<br>
are detached using trypsine/EDTA and pelleted by<br>
C6ntR1fugation. The C6ll pellet is then resuspended in<br>
RPMI culture medium at the appropR1ate C6ll count and<br>
transferred to a 96-well microtitre plate. The plates<br>
are then cultivated overnight in the incubator with gas<br>
inlet. The test substanC6s are made up as stock<br>
solutions in DMSO and, on Test Day 2, diluted with<br>
culture medium to the desired conC6ntrations. The<br>
substanC6s in the culture medium are then added to the<br>
C6lls and incubated in the incubator with gas inlet for<br>
45 h. C6lls which have not been treated with test<br>
substanC6 serve as control.<br>
For the XTT assay, 1 mg/ml of XTT (sodium 3'-[l-<br>
(phenylaminocarbonyl)-3,4-tetrazolium]-bis(4-methoxy-6-<br>
nitro)benzenesulfonic aC1d) is dissolved in RPMI-1640<br>
medium without Phenol Red. Additionally, a 0.383 mg/ml<br>
solution of PMS (N-methyldibenzopyrazine methyl<br>
sulfate) in phosphate-buffered saline (PBS) is<br>
prepared. On Test Day 4, 75 Hi/well of the XTT-PMS<br>
mixture are pipetted onto the C6ll plates, which by now<br>
have been incubated with the test substanC6s for 45 h.<br>
To this end, the XTT solution is mixed with the PMS<br>
solution in a ratio of 50:1 (v/v) shortly before use.<br>
The C6ll plates are then incubated in the incubator<br>
with gas inlet for a further 3 h, and the optical<br>
density (OD490nm) is determined in a photometer.<br>
Using the OD490nm obtained, the inhibition in perC6nt<br>
relative to the control is calculated. The<br>
antiproliferative activity is estimated using<br>
regression analysis.<br>
Example I<br>
Tablet containing 50 mg of active compound<br>
Composition:<br>
(1) Active compound 50.0 mg<br>
(2) Lactose 98.0 mg<br>
(3) Maize starch 50.0 mg<br>
(4) Polyvinylpyrrolidone 15.0 mg<br>
(5) Magnesium stearate 2.0 mg<br>
Total: 215.0 mg<br>
Preparation:<br>
(1), (2) and (3) are mixed and granulated with an<br>
aqueous solution of (4). The dR1ed granules are admixed<br>
with (5). This mixture is tabletted.<br>
Example II<br>
Capsule containing 50 mg of active compound<br>
Composition:<br>
(1) Active compound 50.0 mg<br>
(2) Maize starch, dR1ed 58.0 mg<br>
(3) Lactose powder 50.0 mg<br>
(4) Magnesium stearate 2.0 mg<br>
Total: 160.0 mg<br>
Preparation:<br>
(1) is ground with (3) . This ground mateR1al is added<br>
with vigorous mixing to the mixture of (2) and (4).<br>
This powder mixture is, on a capsule filling machine,<br>
filled into hard gelatine capsules size 3.<br>
We Claim:<br>
1. AC1-idine compounds according to the formula I<br>
in which<br>
R, R1, R2, R3 can be attached to any of the aC1-idine carbon atoms C1 to<br>
C9, are identical or different and independently of one another denote<br>
hydrogen, straight-chain or branched (C1-C8)-alkyl, (C3-C7)-cycloalkyl,<br>
straight-chain or branched (C1-C8)-alkylcarbonyl, preferably acetyl,<br>
straight-chain or branched (C1-C8)-alkoxy, halogen, aryl-(C1-C8)-alkoxy,<br>
preferably benzyloxy or phenylethyloxy, nitro, amino, mono-(C1-C4,)-<br>
alkylamino, di-(C1-C4)-alkylamino, (C1-C8)-alkoxycarbonyl-amino (C1<br>
C6)-alkoxycarbonyiamino-(C1-C8)-alkyl, cyano, straight-chain or<br>
branched cyano-(C1-C6)-alkyl5 carbonyl, (C1-Cg)-alkoxy-carbonyl, (C1-<br>
C4)-alkyl which is substituted by one or more fluoR1ne atoms, preferably<br>
the tR1fluorom ethyl group, carboxy-(C1-C8)-alkyl or (C1-C3)-<br>
alkoxycarbonyl-(C1-C6)-alkyl, (C2-C6)-alkenyl, preferably allyl, (C2-C6)-<br>
alkynyl, preferably ethynyl or propargyl, straight-chain or branched<br>
cyano-(C1-C6)-<br>
alkyl, preferably cyanomethyl, aryl, where<br>
the aryl radical may be unsubstituted or<br>
mono- or polysubstituted by identical or<br>
different substituents from the group<br>
consisting of halogen, straight-chain or<br>
branched (C1-C8) -alkyl, (C3-C7) -cycloalkyl,<br>
carboxyl, straight-chain or branched (C1-C6)-<br>
alkoxycarbonyl, preferably tert-<br>
butoxycarbonyl, by trifluoromethyl, hydroxyl,<br>
straight-chain or branched (C1-C6)-alkoxy,<br>
preferably methoxy or ethoxy, benzyloxy,<br>
nitro, amino, mono-(C1-C4)-alkylamino, di-(C1-<br>
C4)-alkylamino, cyano, straight-chain or<br>
branched cyano- (C1-C6) -alkyl,<br>
substituted on the aC11dine heterocycle may<br>
be attached to C atoms C1-C9 of the aC11dine<br>
R1ng skeleton;<br>
independently of one another represent oxygen or<br>
in each case two hydrogen atoms (i.e. -CH2-) ;<br>
is nitrogen or C-R5, where R5 represents hydrogen<br>
or (C1-C6) -alkyl ;<br>
independently of one another denotes an integer<br>
between 0-3, with the proviso that in the case n =<br>
0, X denotes a CR5R6 group where R5 and R6<br>
independently of one another represent hydrogen or<br>
(C1-C6) -alkyl and that the nitrogen atom adjaC6nt<br>
to the C=Z group is substituted by a hydrogen atom<br>
or a (C-C6)-alkyl group;<br>
R4 Haqunel a straight-chain or branched (C1-C20)-<br>
alkyl radical which may be saturated or un-<br>
saturated, with one to three double and/or tR1ple<br>
bonds, and which may be unsubstituted or may<br>
optionally be substituted at the same or different<br>
C atoms by one, two or more aryl, heteroaryl,<br>
halogen, cyano, (C1-C6)-alkoxycarbonylamino,<br>
(C1-C6) -alkoxy, amino, mono-(C1-C4)-alkylamino or<br>
di-(C1-7C4)-alkylamino; a (C6-C14)-aryl radical, (C6-<br>
C14)-aryl-(C1-C4)-alkyl radical or a (C2-C10)-<br>
heteroaryl or (C2-C10) -heteroaryl- (C1-C4) -alkyl<br>
radical which contains one or more heteroatoms<br>
selected from the group consisting of N, 0 and S,<br>
where the (C1-C4) -alkyl radical may be<br>
unsubstituted or mono- Haqune polysubstituted by<br>
identical or different substituents from the group<br>
consisting of (C1-C6) -alkyl., halogen and oxo (=0)<br>
and where the (C6-C14) -aryl or (C2-C10) -heteroaryl<br>
radical may be unsubstituted or mono- or polysubstituted<br>
by identical or different substituents<br>
from the group consisting of straight-chain or<br>
branched (C1-C8)-alkyl, (C3-C7) -cycloalkyl,<br>
halogen, cyano, (C1-C6)-alkoxycarbonylamino,<br>
(C1-C6)-alkoxy, carboxyl, (C1-C8)-alkoxycarbonyl,<br>
straight-chain or branched (C1-C6) -alkyl which is<br>
substituted by one or more fluoR1ne atoms,<br>
preferably tR1fluoromethyl, hydroxyl, straight-<br>
chain or branched (C1-C8) -alkoxy, preferably<br>
methoxy or ethoxy, where adjaC6nt oxygen atoms may<br>
also be linked by (C1-C2) -alkylene groups,<br>
preferably by a methylene group, benzyloxy, nitro,<br>
amino, mono-(C1-C4)-alkylamino, di-(C1-C4)-alkyl-<br>
amino, aryl, which for its part may be<br>
unsubstituted or mono- or polysubstituted by<br>
identical or different substituents from the group<br>
consisting of straight-chain or branched (C1-C6)-<br>
alkyl, (C3-C7)-cycloalkyl, carboxyl, straight-chain or branched (C1<br>
C8)-alkoxycarbonyl, by trifluoromethyl, hydroxyl, straight-chain or<br>
branched (C1-C8)-alkoxy, preferably methoxy or ethoxy, benzyl-oxi<br>
nitro, ammo, mono-(C1-C4)-alkylamino, di-(C1-C4)-alkylamino,<br>
cyano, straight-chain or branched cyano-(C1-C6)-alkyl;<br>
and their structural isomers and stereoisomers, in particular tautorners,<br>
diastereomers and enantiomers, and their pharmaceutically acceptable<br>
salts, in particular acid addition salts.<br>
Acridine compounds of the formula 1 as claimed in claim 1, wherein<br>
R, Rl, R2, R3, X, Z, P, Q, n and m have the meanings given in claim<br>
1 and<br>
R4 denotes a straight-chain or branched (CVC20)- alky' radical<br>
which may be saturated or unsaturated, with one to three double<br>
and/or triple bonds, and which may be unsubstituted or optionally<br>
substituted on the same or different C atoms by one, two or more aryl,<br>
heteroaryl, halogen, (Cl-C6)-alkoxy, amino, mono-(C1-C4)-<br>
alkylamino or di-(C1-C4)-alkylamino;<br>
A phenyl ring or a naphthyl ring, each of which may be unsubstituted<br>
or mono- or polysubstituted by identical or different substituents from<br>
the group consisting of straight-chain or branched (C1-Cg)-alkyl, (C3-<br>
C7)-cycloalkyl, halogen, cyano, (C1-C6)-alkoxycarbonylamino, (C1<br>
C8)-alkoxy, carboxyl, (C1-C8)-alkoxycarbonyl, straight-chain or<br>
branched (C1-C6)-alkyl which is substituted by one or more fluorine<br>
atoms, preferably trifluorom ethyl, hydroxyl, straight-chain or<br>
branched (C1-C8)-aifcoxy, preferably methoxy or<br>
ethoxy, benzyloxy, nitro, amino, mono-(C1-C4) -<br>
alkylamino, di- (C1-C4) -alkylamino, aryl, which<br>
for ' its part may be unsubstituted or mono- or<br>
polysubstituted by identical or different<br>
substituents from the group consisting of<br>
straight-chain or branched (C1-C8)-alkyl,<br>
(C3-C7) -cycloalkyl, carboxyl, straight-chain or<br>
branched (C1-C8)-alkoxycarbonyl, by tR1fluoro-<br>
methyl, hydroxyl, straight-chain or branched<br>
(C1-C8)-alkoxy, preferably methoxy or ethoxy,<br>
benzyloxy, nitro, amino, mono- (C1-C4) -<br>
alkylamino, di-(C1-C4)-alkylamino, cyano,<br>
straight-chain or branched cyano- (C1-C6) -alkyl ;<br>
a 2-, 4-, 5- or 6-pyR1midinyl radical or 2-,<br>
4-, 5- or 6-pyR1midinyl-(C1-C4)-alkyl radical,<br>
where the (C1-C4)-alkyl radical may be<br>
unsubstituted or mono- [lacuna] polysubstituted<br>
by identidal or different substituents from the<br>
group consisting of (C1-C6) -alkyl, halogen and<br>
oxo (=0) and the 2-, 4-, 5- or 6-pyR1midinyl<br>
radical may be unsubstituted or mono- to<br>
tR1substituted by identical or different<br>
substituents from- the group consisting of<br>
hydrogen, (C1-C6) -alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonyl-<br>
amino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluoR1ne, preferably tR1-<br>
f luoromethyl, (C6-C10) -aryl and (C6-C10) -aryl-<br>
(C1-C6) -alkyl;<br>
a 3-, 4-, 5- or 6-pyR1dazinyl radical or 3-,<br>
4-, 5- or 6-pyR1dazinyl-(C1-C4)-alkyl radical,<br>
where the (C1-C4) -alkyl radical may be<br>
unsubstituted or mono- [lacuna] polysubstituted<br>
by identical or different substituents from the<br>
group consisting of (C1-C6)-alkyl, halogen and<br>
oxo (=0) and the 3-, 4-, 5- or 6-pyR1dazinyl<br>
radical may be unsubstituted or mono- to<br>
tR1substituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonyl-<br>
amino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluoR1ne, preferably<br>
tR1fluoromethyl, (C6-C10) -aryl and (C6-C10) -aryl-<br>
(C1-C6)-alkyl ;<br>
a 2-, 3-, 5- or 6-pyrazinyl radical or 2-, 3-,<br>
5- or 6-pyrazinyl-(C1-C4)-alkyl radical, where<br>
the (C1-C4)-alkyl radical may be unsubstituted<br>
or mono- [lacuna] polysubstituted by identidal<br>
or different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo<br>
(=0) and the 2-, 3-, 5- or 6-pyrazinyl radical<br>
may be unsubstituted or mono- to tR1substituted<br>
by identical or different substituents from the<br>
group consisting of hydrogen, (C1-C6) -alkyl,<br>
halogen, nitro, amino, mono- (C1-C6) -alkylamino,<br>
di-(C1-C6)-alkylamino, hydroxyl, (C1-C6) -alkoxy,<br>
benzyloxy, carboxyl, (C1-C6)-alkoxycarbonyl,<br>
(C1-C6) -alkoxycarbonylamino or (C1-C6) -alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10)-aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 3-, 4-, 5-, 6-, 7-, or 8-C1nnolinyl radical<br>
or 3-, 4-, 5-, 6-, 7-, or 8-C1nnolinyl-(C1-C4) -<br>
alkyl radical, where the (C1-C4) -alkyl radical<br>
may be unsubstituted or mono- [lacuna]<br>
polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-<br>
C6)-alkyl, halogen and oxo (=0) and the 3-, 4-,<br>
5-, 6-, 7-, or 8-C1nnolinyl radical may be<br>
unsubstituted or mono- to pentasubstituted by<br>
identical or different substituents from the<br>
group consisting of hydrogen, (C1-C6)-alkyl,<br>
halogen, nitro, amino, mono- (C1-C6) -alkylamino,<br>
di-(C1-C6)-alkylamino, hydroxyl, (C1-C6) -alkoxy,<br>
benzyloxy, carboxyl, (C1-C6) -alkoxycarbonyl,<br>
(C1-C6) -alkoxycarbonylamino or (C1-C6) -alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10) -aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl ;<br>
a 2-, 4-, 5-, 6-, 7-, or 8-quinazolinyl radical<br>
or 2-, 4-, 5-, 6-, 7-, or 8-quinazolinyl-(C1-<br>
C4)-alkyl radical, where the (C1-C4)-alkyl<br>
radical may be unsubstituted or mono- [lacuna]<br>
polysubstituted by identidal or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6) -alkyl, halogen and oxo (=0)<br>
and the or [sic] 2-, 4-, 5-, 6-, 7-, or<br>
8-quinazolinyl radical may be unsubstituted or<br>
mono- to pentasubstituted by identical or<br>
different substituents from the group<br>
consisting of hydrogen, (C1-C6)-alkyl, halogen,<br>
nitro, amino, mono- (C1-C6) -alkylamino, di-(C1-<br>
C6)-alkylamino, hydroxyl, (C1-C6) -alkoxy, benz-<br>
yloxy, carboxyl, (C1-C6)-alkoxycarbonyl, (C1-<br>
C6)-alkoxycarbonylamino or (C1-C6) -alkyl which<br>
is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10) -aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 2-, 3-, 5-, 6-, 7-, or 8-quinoxalinyl radical<br>
[lacuna] 2-, 3-, 5-, 6-, 1-, or 8-quinoxalinyl-<br>
(C1-C4) -alkyl radical, where the {C1-C4) -alkyl<br>
radical may be unsubstituted or mono- [diffrent]<br>
polysubstituted by identidal or different<br>
substituents from the group consisting of<br>
(C1-C6) -alkyl, halogen and oxo (=0) and the or<br>
[sic] 2-, 3-, 5-, 6-, 7-, or 8-quinoxalinyl<br>
radical may be unsubstituted or mono- to<br>
pentasubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6) -alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonyl-<br>
amino or (C1-C6)-alkyl which is mono- or<br>
polysubstituted by fluoR1ne, preferably<br>
. tR1fluoromethyl, (C6-C10) -aryl and (C6-C10) -aryl-<br>
(C1-C6)-alkyl ;<br>
a 1-, 4-, 5-, 6-, 7-, or 8-phthalazinyl radical<br>
or 1-, 4-, 5-, 6-, 7-, or 8-phthalazinyl-<br>
(C1-C4)-alkyl radical, where the (C1-C4)-alkyl<br>
radical may be unsubstituted or mono- [lacuna]<br>
polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-<br>
C6)-alkyl, halogen and oxo (=0) and the or<br>
[sic] 1-, 4-, 5-, 6-, 7-, or 8-phthalazinyl<br>
radical may be unsubstituted or mono- to<br>
pentasubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6) -alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonyl-<br>
amino or (C1-C6)-alkyl which is mono- or<br>
polysubstituted by fluoR1ne, preferably<br>
tR1fluoromethyl, (C6-C10)-aryl and (C6-C10) -aryl-<br>
(d-C6) -alkyl;<br>
a 2-, 3-, 4-, 5-, 6-, 7- or 8-quinolyl radical<br>
or 2-, 3-, 4-, 5-, 6-, 7 or 8-quinolyl-(C1-C4)-<br>
alkyl radical, where the (C1-C4) -alkyl radical<br>
may be unsubstituted or mono- or polysubstituted<br>
by identidal or different<br>
substituents from the group consisting of<br>
(C1-C6)-alkyl, halogen and oxo (=0) and the 2-,<br>
3-, 4-, 5-, 6-, 7- or 8-quinolyl radical may be<br>
unsubstituted or mono- to hexasubstituted by-<br>
identical or different substituents from the<br>
group consisting of hydrogen, (C1-C6)-alkyl,<br>
preferably methyl, particularly preferably<br>
2-methyl, halogen, nitro, amino, mono-(C1-C6)-<br>
alkylamino, di- (C1-C6) -alkylamino, hydroxyl,<br>
(C1-C6) -alkoxy, benzyloxy, carboxyl, (C1-C6)-<br>
alkoxycarbonyl, (C1-C6) -alkoxycarbonylamino or<br>
(C1-C6) -alkyl which is mono- or polysubstituted<br>
by fluoR1ne, preferably tR1fluoromethyl,<br>
(C6-C10)-aryl and (C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 1-, 3-, 4-, 5-, 6-, 7- or 8-isoquinolyl<br>
radical or 1-, 3-, 4-, 5-, 6-, 7- or 8-<br>
isoquinolyl-{C1-C4)-alkyl radical, where the<br>
(C1-C4) -alkyl radical may be unsubstituted or<br>
mono- or polysubstituted by identidal or<br>
different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo<br>
(=0) and the 1-, 3-, 4-, 5-, 6-, 7- or 8-<br>
isoquinolyl radical may be unsubstituted or<br>
mono- to hexasubstituted by identical or<br>
different substituents from the group<br>
consisting of hydrogen, (C1-C6)-alkyl, halogen,<br>
nitro, amino, mono-(C1-C6)-alkylamino, di-<br>
(C1-C6)-alkylamino, hydroxyl, (C1-C6)-alkoxy,<br>
benzyloxy, carboxyl, (C1-C6)-alkoxycarbonyl,<br>
(C1-C6)-alkoxycarbonylamino or (C1-C6) -alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10)-aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl ;<br>
a 2-, 6-, 8- or 9- [9H] -puR1nyl radical or 2-,<br>
6-, 8- or 9-[9H]-puR1nyl-(C1-C4)-alkyl radical,<br>
where the (C1-C4)-alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the<br>
group consisting of (C1-C6) -alkyl, halogen and<br>
oxo (=0) and the 2-, 6-, 8- or 9- [9H] -puR1nyl<br>
radical may be unsubstituted or mono- to<br>
tR1substituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6) -alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonyl-<br>
amino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluoR1ne, preferably<br>
tR1fluoromethyl, (C6-C10) -aryl and (C6-C10) -aryl-<br>
(C1-C6)-alkyl;<br>
a 2-, 6-, 7- or 8- [7H] -puR1nyl radical or 2-,<br>
6-, 7- or 8-[7H]-puR1nyl-(C1-C4)-alkyl radical,<br>
where the (C1-C4)-alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the<br>
group consisting of (C1-C6) -alkyl, halogen and<br>
oxo (=0) and the 2-, 6-, 7- or 8- [1H] -puR1nyl<br>
radical may be unsubstituted or mono- to<br>
tR1substituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, {C1-C6) -alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylantino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6) -alkoxy, benzyloxy, carboxyl,<br>
(C1-C6)-alkoxycarbonyl, (C1-C6)-<br>
alkoxycarbonylamino or (C1-C6) -alkyl which is<br>
mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10) -aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-acridinyl<br>
radical or 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or<br>
9-acridinyl-(C1-C4)-alkyl radical, where the<br>
(C1-C6)-alkyl radical may be unsubstituted or<br>
mono- or polysubstituted by identidal or<br>
different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo<br>
(=0) and the 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or<br>
9-aC11dinyl radical may be unsubstituted or<br>
mono- to octasubstituted by identical or<br>
different substituents from the group<br>
consisting of hydrogen, (C1-C6)-alkyl, halogen,<br>
nitro, amino, mono- (C1-C6) -alkylamino, di-(C1-<br>
C6)-alkylamino, hydroxyl, (C1-C6) -alkoxy,<br>
benzyloxy, carboxyl, (C1-C6) -alkoxycarbonyl,<br>
(C1-C6)-alkoxycarbonylamino or (C1-C6) -alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10)-aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-<br>
phenanthR1dinyl radical or 1-, 2-, 3-, 4-, 5-,<br>
6-, 7-, 8- or 9-phenanthR1dinyl-(C1-C6)-alkyl<br>
radical, where the (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the<br>
group consisting of hydrogen, (C1-C6) -alkyl,<br>
halogen and oxo (=0) and the 1-, 2-, 3-, 4-,<br>
5-, 6-, 7-, 8- or 9-phenanthR1dinyl radical may<br>
be unsubstituted or mono- to octasubstituted by<br>
identical or different substituents from the<br>
group consisting of (C1-C6) -alkyl, halogen,<br>
nitro, amino, mono- (C1-C6) -alkylamino, di-<br>
(C1-C6)-alkylamino, hydroxyl, (C1-C6)-alkoxy,<br>
(C6-C10)-aryl-(C1-C6)-alkoxy, preferably benzyl-<br>
oxy, carboxyl, (C1-C6)-alkoxycarbonyl, (C1-C6)-<br>
alkoxycarbonylamino or (C1-C6) -alkyl which is<br>
mono- or polysubstituted by fluoR1ne,<br>
preferably tR1f luoromethyl, (C6-C10) -aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl ;<br>
a 2-, 3-, 4-, 5- or 6-pyR1dyl radical where the<br>
2-, 3-, 4-, 5- or 6-pyR1dinl [sic] radical may<br>
be unsubstituted or mono- to tetrasubstituted<br>
by identical or different substituents from the<br>
group consisting of hydrogen, (C1-C6) -alkyl,<br>
halogen, nitro, amino, mono- (C1-C6) -alkylamino,<br>
di-(C1-C6)-alkylamino, hydroxyl, (C1-C6) -alkoxy.<br>
benzyloxy, carboxyl, (C1-C6)-alkoxycarbonyl,<br>
(C1-C6)-alkoxycarbonylamino or (d-C6)-alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10) -aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 2-, 3-, 4-, 5- or 6-pyR1dyl-(C1-C6)-alkyl<br>
radical, where the (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identical or different substituents from the<br>
group consisting of (C1-C6)-alkyl, halogen and<br>
oxo (=0) and the 2-, 3-, 4-, 5- or 6-pyR1dinyl<br>
radical may be unsubstituted or mono- to<br>
tetrasubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonyl-<br>
amino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluoR1ne, preferably<br>
tR1f luoromethyl, (C6-C10) -aryl and (C6-C10) -aryl-<br>
(C1-C6)-alkyl;<br>
a 2-, 3-, 4- or 5-thienyl radical or 2-, 3-, 4-<br>
or 5-thienyl-(C1-C6)-alkyl radical, where the<br>
(C1-C6) -alkyl radical may be unsubstituted or<br>
mono- or polysubstituted by identidal or<br>
different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo<br>
(=0) and the 2-, 3-, 4- or 5-thienyl radical<br>
may be unsubstituted or mono- to tR1substituted<br>
by identical or different substituents from the<br>
group consisting of hydrogen, (C1-C6) -alkyl,<br>
halogen, nitro, amino, mono- (C1-Cg) -alkylamino,<br>
di- (C1-C6) -alkylamino, hydroxyl, (C1-C6) -alkoxy,<br>
benzyloxy, carboxyl, (C1-C6)-alkoxycarbonyl,<br>
(C1-C6) -alkoxycarbonylamino or (C1-C6)-alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10) -aryl and<br>
(C6-C10) -aryl- (d-C6) -alkyl;<br>
a 2-, 4-, or 5-thiazolyl radical or 2-, 4-, or<br>
5-thiazolyl-(C1-C6)-alkyl radical, where the<br>
(C1-C6)-alkyl radical may be unsubstituted or<br>
mono- or polysubstituted by identidal or<br>
different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo<br>
(=0) and the 2-, 4-, or 5-thiazolyl radical may<br>
be unsubstituted or mono- or disubstituted by<br>
identical or different substituents from the<br>
group consisting of hydrogen, (C1-C6) -alkyl,<br>
halogen, nitro, amino, mono- (C1-C6) -alkylamino,<br>
di-(C1-C6)-alkylamino, hydroxyl, (C1-C6) -alkoxy,<br>
benzyloxy, carboxyl, (C1-C6) -alkoxycarbonyl,<br>
(C1-C6) -alkoxycarbonylamino or (C1-C6) -alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10) -aryl and<br>
(C6-C10) -aryl- (d-C6) -alkyl ;<br>
a 3-, 4-, or 5-isothiazolyl radical or 3-, 4-,<br>
or 5-isothiazolyl-(C1-C6)-alkyl radical, where<br>
the (C1-C6)-alkyl radical may be unsubstituted<br>
or mono- or polysubstituted by identidal or<br>
different substituents from the group<br>
consisting of (C1-C6)-alkyl, halogen and oxo<br>
(=0) and the 3-, 4-, or 5-isothiazolyl radical<br>
may be unsubstituted or mono- or disubstituted<br>
by identical or different substituents from the<br>
group consisting of hydrogen, (C1-C6) -alkyl,<br>
halogen, nitro, amino, mono- (C1-C6) -alkylamino,<br>
di-(C1-C6)-alkylamino, hydroxyl, (C1-C6) -alkoxy,<br>
benzyloxy, carboxyl, (C1-C6)-alkoxycarbonyl,<br>
(C1-C6) -alkoxycarbonylamino or (d-C6)-alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-do) -aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 2-, 4-, 5-, 6-, or 7-benzothiazolyl radical<br>
or 2-, 4-, 5-, 6-, or 7-benzothiazolyl-(C1-C6) -<br>
alkyl radical, where the (C1-C6) -alkyl radical<br>
may be unsubstituted or mono- or<br>
polysubstituted by identidal or different<br>
substituents from the group consisting of<br>
(C1-C6)-alkyl, halogen and oxo (=0) and the 2~,<br>
4-, 5-, 6-, or 7-benzothiazolyl radical may be<br>
unsubstituted or mono- to tetrasubstituted by<br>
identical or different substituents from the<br>
group consisting of hydrogen, (C1-C6)-alkyl,<br>
halogen, nitro, amino, mono- (C1-C6) -alkylamino,<br>
di-(C1-C6)-alkylamino, hydroxyl, (C1-C6) -alkoxy,<br>
benzyloxy, carboxyl, (C1-C6) -alkoxycarbonyl,<br>
(C1-C6) -alkoxycarbonylamino or (C1-C6)-alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10)-aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 1-, 2-, 4-, or 5-imidazolyl radical or 1-,<br>
2-, 4-, or 5-imidazolyl-(C1-C6)-alkyl radical,<br>
where the (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the<br>
group consisting of (C1-C6) -alkyl, halogen and<br>
oxo (=0) and the 1-, 2-, 4-, or 5-imidazolyl<br>
radical may be unsubstituted or mono- to<br>
tR1substituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6) -alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonyl-<br>
amino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluoR1ne, preferably<br>
tR1f luoromethyl, (C6-C10) -aryl and (C6-C10)-aryl-<br>
(C1-C6)-alkyl;<br>
a 1-, 3-, 4-, or 5-pyrazolyl radical or 1-, 3-,<br>
4- or 5-pyrazolyl-(C1-C6)-alkyl radical, where<br>
the (C1-C6) -alkyl radical may be unsubstituted<br>
or mono- or polysubstituted by identidal or<br>
different substituents from the group<br>
consisting of (C1-C6)-alkyl, halogen and oxo<br>
(=0) and the 1-, 3-, 4- or 5-pyrazolyl radical<br>
may be unsubstituted or mono- to tR1substituted<br>
by identical or different substituents from the<br>
group consisting of hydrogen, (C1-C6) -alkyl,<br>
halogen, nitro, amino, mono- (C1-C6) -alkylamino,<br>
di-(C1-C6)-alkylamino, hydroxyl, (C1-C6) -alkoxy,<br>
benzyloxy, carboxyl, (C1-C6)-alkoxycarbonyl,<br>
(C1-C6) -alkoxycarbpnylanuno or (C1-C6) -alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10) -aryl and<br>
(C6-Clo) -aryl- (C1-C6) -alkyl ;<br>
a 1-, 2-, 3-, 4-, or 5-pyrrolyl radical or 1-,<br>
2-, 3-, 4-, or 5-pyrrolyl-(C1-C6)-alkyl radical,<br>
where the (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the<br>
group consisting of (C1-C6) -alkyl, halogen and<br>
oxo (=0) and the 1-, 2-, 3-, 4- or 5-pyrrolyl<br>
radical may be unsubstituted or mono- to<br>
tetrasubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (d-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- {C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonyl-<br>
amino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluoR1ne, preferably<br>
tR1fluoromethyl, (C6-C10) -aryl and (C6-C10) -aryl-<br>
(C1-C6)-alkyl;<br>
a 1-, 3-, or 5-[1.2.4]-tR1azolyl radical or 1-,<br>
3-, or 5-[1.2.4]-tR1azolyl-(C1-C6)-alkyl<br>
radical, where the (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidai or different substituents from the<br>
group consisting of hydrogen, (C1-C6)-alkyl,<br>
halogen and oxo (=0) and the 1-, 3-, or 5-<br>
[1.2.4]-tR1azolyl radical may be unsubstituted<br>
or mono- or disubstituted by identical or<br>
different substituents from the group<br>
consisting of (C1-C6)-alkyl, halogen, nitro,<br>
amino, mono- (C1-C6) -alkylamino, di-(C1-C6)-<br>
alkylamino, hydroxyl, (d-C6)-alkoxy, benzyloxy,<br>
carboxyl, (C1-C6) -alkoxycarbonyl, (C1-C6)-<br>
alkoxycarbonylamino or (C1-C6) -alkyl which is<br>
mono- or polysubstituted by fluoR1ne,<br>
preferably trifluoromethyl, (C6-C10)-aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 1-, 4-, or 5-[1.2.3]-tR1azolyl radical or 1-,<br>
4-, or 5-[1.2.3]-triazolyl-(C1-C6)-alkyl<br>
radical, where the (C1-C6)-alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidai or different substituents from the<br>
group consisting of (C1-C6) -alkyl, halogen and<br>
oxo (=0) and the 1-, 4-, or 5-[1.2.3]-triazolyl<br>
radical may be unsubstituted or mono- or<br>
disubstituted by identical or different<br>
substituents from the group consisting of<br>
hydrogen, (C1-C6) -alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (d-C6) -alkylamino,<br>
hydroxyl, {C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
{C1-C6) -alkoxycarbonyi, (C1-C6) -alkoxycarbonyl-<br>
amino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluoR1ne, preferably<br>
tR1f luoromethyl, (C6-C10) -aryl and (C6-C10) -aryl-<br>
(C1-C6) -alkyl;<br>
a 1- or 5-[lH]-tetrazolyl radical or 1-, or 5-<br>
[lH]-tetrazolyl-(C1-C6)-alkyl radical, where the<br>
(C1-C6) -alkyl radical may be unsubstituted or<br>
mono- or polysubstituted by identidal or<br>
different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo<br>
(=0) and the 1-, or 5-[1H] -tetrazolyl radical<br>
may be unsubstituted or substituted by<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) -alkoxycarbonyl-<br>
amino or (C1-C6)-alkyl which is mono- or<br>
polysubstituted by fluoR1ne, preferably<br>
tR1fluoromethyl, (C6-C10) -aryl and (C6-C10) -aryl-<br>
(C1-C6) -alkyl;<br>
a 2- or 5-[2H) -tetrazoyl radical or 2- or<br>
5-[2H]-tetrazolyl-(C1-C6)-alkyl radical, where<br>
the (C1-C6) -alkyl radical may be unsubstituted<br>
or mono- or polysubstituted by identidal or<br>
different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo<br>
(=0) and the 2- or 5- [2H] -tetrazolyl radical<br>
may be unsubstituted or substituted by<br>
hydrogen, (C1-C6)-alkyl, halogen, nitro, amino,<br>
mono- (C1-C6) -alkylamino, di- (C1-C6) -alkylamino,<br>
hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl,<br>
(C1-C6) -alkoxycarbonyl, (C1-C6) - alkoxycarbonyl-<br>
amino or (C1-C6) -alkyl which is mono- or<br>
polysubstituted by fluoR1ne, preferably<br>
tR1fluoromethyl, (C6-C10)-aryl and (C6-C10) -aryl-<br>
(C1-C6) -alkyl;<br>
a 2-, 4-, or 6-[1.3.5]-tR1azinyl radical or 2-,<br>
4-, or 6-[1.3. 5]-tR1azinyl-(C1-C6)-alkyl<br>
radical, where the (C1-C6) -alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by<br>
identidal or different substituents from the<br>
group consisting of hydrogen, (C1-C6) -alkyl,<br>
halogen and oxo (=0) and the 2-, 4-, or 6-<br>
[1.3.5]-tR1azinyl radical may be unsubstituted<br>
or mono- or disubstituted by identical or<br>
different substituents from the group<br>
consisting of hydrogen, (C1-C6) -alkyl, halogen,<br>
nitro, amino, mono- (C1-C6) -alkylamino, di-<br>
(C1-C6)-alkylamino, hydroxyl, (C1-C6) -alkoxy,<br>
benzyloxy, carboxyl, (C1-C6)-alkoxycarbonyl,<br>
(C1-C6)-alkoxycarbonylamino or (C1-C6) -alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably tR1fluoromethyl, (C6-C10)-aryl and<br>
(C6-C10) -aryl- (C1-C6) -alkyl;<br>
a 2-, 4-, or 5-oxazolyl radical or 2-, 4-, or<br>
5-oxazolyl-(C1-C6)-alkyl radical, where the (C1-<br>
C6)-alkyl radical may be unsubstituted or mono-<br>
or polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-<br>
C6)-alkyl, halogen and oxo (=0) and the 2-, 4-,<br>
or 5-oxazolyl radical may be unsubstituted or<br>
mono- or disubstituted by identical or<br>
different substituents from the group<br>
consisting of hydrogen, (C1-C6) -alkyl, halogen,<br>
nitro, amino, mono- (C1-C6) -alkylamino, di-(C1-<br>
C6) -alkylamino. hydroxyl, (C1-C6)-alkoxy,<br>
benzyloxy, carboxyl, (C1-C6) -alkoxycarbonyl,<br>
(C1-C6)-alkoxycarbonylamino or (C1-C6) -alkyl<br>
which is mono- or polysubstituted by fluoR1ne,<br>
preferably trifluoromethyl, (C6-C10) -aryl and<br>
 (C6-C10)-aryl-(C1-C6)-alkyl;<br>
a 3-, 4-, or 5-isoxazolyl radical or 3-, 4-, or<br>
5-isoxazolyl-(C1-C6)-alkyl radical, where the<br>
(C1-C6)-alkyl radical may be unsubstituted or<br>
mono- or polysubstituted by identidal or<br>
different substituents from the group<br>
consisting of (C1-C6) -alkyl, halogen and oxo<br>
(=0) and the 3-, -4-, or 5-isoxazolyl radical<br>
may be unsubstituted or mono- or disubstituted<br>
by identical or different substituents from the<br>
group consisting of hydrogen, (C1-C6)-alkyl,<br>
halogen, nitro, amino, mono-(C1-C1)-alkylamino, di-(C1-C6)-<br>
alkylamino, hydroxyi, (C1-C6)-alkoxy, benzyloxy, carboxyl, (C1-C6)- <br>
alkoxycarbonyl, (C1-C6)-alkoxycarbonylamnio or (C1-C6)-alkyl which<br>
is mono- or polysubstituted by fluoR1ne, preferably trifhioromethyl,<br>
(C6-Cl0)-aryl and (C1C10)-tiyl-(C1-C6)-alkyl<br>
a 1-, 2-, 3-, 4-, 5-, 6- or 7-indolyl radical or 1-, 2-, 3-, 4-, 5-, 6- or 7-<br>
indolyl- (C1-C6)- alkyl radical, where the (C1-C6)-alkyl radical may be<br>
unsubstituted or mono- or polysubstituted by identidal or different<br>
substituents from the group consisting of (C1-C6)-alkyl, halogen and<br>
oxo (=0) and the 1-, 2-, 3-, 4-, 5-, 6- or 7-indolyl radical may be<br>
unsubstituted or mono- to hexasubstituted by identical or different<br>
substituents from the group consisting of hydrogen, (C1-C6)-alkyl,<br>
halogen, nitro, amino, mono- (C1-C6)-alkylammo, di-(C1-C6)<br>
alky lam in o, hydroxyl, (C1-C6)-alkoxy, benzyloxy, carboxyl, (C1-C6)-<br>
alkoxycarbonyt, (C1-C6)-alkoxycarbonylamino or (C1-C6)-alkyl which<br>
is mono- or polysubstituted by fluoR1ne, preferably trifluoromethyl,<br>
(C6-C10)-aryl and (C6-C,0)-aryl-(C1-C6)-aikyl.<br>
3. AC11dine compounds as claimed in claim 1 or 2, wherein R, R1, R2,<br>
R3, X, Z, P, Q, n and m have the meanings given above and R4<br>
represents phenyl which is unsubstituted or substituted by one to five<br>
identical or different (C1-C6)-alkoxy groups, where adjaC6nt oxygen<br>
atoms may also be linked by (C1-C2)-alkylene groups.<br>
4, AC11dine compounds as claimed in any of claims 1 to 3, wherein R,<br>
R1, R2, R3, P, Q, X, Z, n and m have the meanings given above and R4<br>
represents 3,5-dimethoxyphenyl.<br>
AC11d me compounds as claimed in any of the preC6ding claims<br>
wherein R4 has the meanings given above, R, R1. R2, R3 eath<br>
represent a hydrogen atom, Z represents an oxygen atom and X<br>
represents a nitrogen atom, P and Q each represent two hydrogen<br>
atoms (i.e -CH2-) and m is zero and n represents the integer 2.<br>
AC11dine compounds as claimed in any of the preC6ding claims,<br>
wherein, R, R1, R2, R3 each represent a hydrogen atom, Z represents<br>
an oxygen atom and X represents a nitrogen atom, P and Q each<br>
represent two hydrogen atoms (i.e -CH2-) and m is zero and n<br>
represents the integer 2, and R4 represents 3, 5-dimethoxyphenyl<br>
AC11dine compounds as claimed in any of claims 1 to 6 for use as<br>
medicaments.<br>
ProC6ss for prepaR1ng aC11dine compounds as claimed in any of claims<br>
1 to 6 wherein an aC11dine carboxylic aC1d of the formula (2) in which<br>
R, Rl, R2, R3 have the meanings given above, Z denotes an oxygen<br>
or sulfur atom and Y represents a leaving group such as halogen,<br>
hydroxyl (Cl-C6)-alkoxy, preferably methoxy or ethoxy, -O-tosyl, -<br>
O-mesyl or imidazolyl,<br>
is reated with an amine of the formula (3) in which R4, X, P, Q, m and<br>
n have the meanings given above, optionally using known diluents<br>
and auxiliaries, the desired aC11dine deR1vative is formed.<br>
9. Medicament comprising, at least one acedine compounds as an active<br>
ingredient as claimed in claims 1 to 6 and optionally together with<br>
known pharmaceutically aceptable auxiliaries, additives and carriers.<br>
The invention relates to novel acridine derivatives of general formula (1) the production thereof and the use of the<br>
same as Pharmaceuticals, especially for treating tumours.</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1hYnN0cmFjdC5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1jbGFpbXMucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1jb3JyZXNwb25kZW5jZS5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-correspondence.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1kZXNjcmlwdGlvbiAoY29tcGxldGUpLnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-description (complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1leGFtaW5hdGlvbiByZXBvcnQucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-examination report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1mb3JtIDEucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1mb3JtIDE4LnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-form 18.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1mb3JtIDIucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-form 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1mb3JtIDI2LnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-form 26.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1mb3JtIDMucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1mb3JtIDUucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1mb3JtIDYucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-form 6.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1ncGEucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-gpa.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1wcmlvcml0eSBkb2N1bWVudC5wZGY=" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-priority document.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1yZXBseSB0byBleGFtaW5hdGlvbiByZXBvcnQucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-reply to examination report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC1zcGVjaWZpY2F0aW9uLnBkZg==" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-specification.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=aW4tcGN0LTIwMDItMTUyOS1rb2wtZ3JhbnRlZC10cmFuc2xhdGVkIGNvcHkgb2YgcHJpb3JpdHkgZG9jdW1lbnQucGRm" target="_blank" style="word-wrap:break-word;">in-pct-2002-1529-kol-granted-translated copy of priority document.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="225483-a-peptide-for-treating-a-patient-having-a-condition-mediated-by-neurotoxicity-neurodegeneration-or-neurological-damage.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="225485-pourable-liquid-vehicles.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>225484</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>IN/PCT/2002/1529/KOL</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>46/2008</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>14-Nov-2008</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>12-Nov-2008</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>16-Dec-2002</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>ZENTARIS GMBH . ,</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>WEISMULLERSTRASSE 45, 60314 FRANKFURT</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>EMIG, PETER</td>
											<td>LUDWIG - ERHARD - STR. 22 63486 BRUCHKOBEL DEUTSCHLAND</td>
										</tr>
										<tr>
											<td>2</td>
											<td>GUNTHER, ECKHARD</td>
											<td>WINGERTSTR. 176 63477 MAINTAL DEUTSCHLAND</td>
										</tr>
										<tr>
											<td>3</td>
											<td>BACHER, GERALD</td>
											<td>KRIEGERSTR. 62 82110 GERMERING DEUTSCHLAND</td>
										</tr>
										<tr>
											<td>4</td>
											<td>BECKERS, THOMAS</td>
											<td>PASSAVANT - STR. 26 60596 FRANKFURT</td>
										</tr>
										<tr>
											<td>5</td>
											<td>AUE, BEATE</td>
											<td>VALENTIN - HOCK - STR. 32 63762 GROBOSTHEIM / RINGHEIM DEUTSCHLAND</td>
										</tr>
										<tr>
											<td>6</td>
											<td>NICKEL, BERND</td>
											<td>ALLEESTR. 35 64367 MUHTAL DEUTSCHLAND</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07D 219/04</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP01/08263</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2001-07-18</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>100 35 927.2</td>
									<td>2000-07-21</td>
								    <td>Germany</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/225484-acridine-compounds-a-process-of-preparing-the-same by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 04 Apr 2024 23:59:10 GMT -->
</html>
